Associate Professor, Department of Biomedical Engineering, University of Connecticut Health Center
BIOGRAPHY
Speaker
Abstract
The recent outbreak of the Coronavirus Disease 2019 (COVID-19) has spread all over the world and raised global concerns. Rapid and early detection of the novel coronavirus SARS-CoV-2, the causative agent of the COVID-19, plays a crucial role in reducing transmission of the virus and facilitating early intervention and treatment. In this talk, I will present our CRISPR-based nucleic acid detection technology for SARS-CoV-2 testing. I will also introduce our effort on developing low-cost CRISPR-based diagnostic devices and instrument-free detection platforms, enabling simple, rapid, affordable, mobile, point of care molecular diagnostics.
Learning Objectives:
1. Discuss current challenges in developing simple and rapid molecular diagnostic assay to fight COVID-19.
2. Introduce new CRISPR-based molecular diagnostic technologies.
3. Present CRISPR-based microfluidic diagnostic system for SARS-CoV-2 detection at the point of care.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...